Research

Hormonal

Natural peptides (BRP, BPC-157, MOTS-c) offer a safer, more metabolically specific alternative to semaglutide for obesity management by preserving lean mass and avoiding severe gastrointestinal side effects.

Natural peptides like BRP, BPC-157, and MOTS-c are emerging as potential alternatives to semaglutide, offering weight loss with better preservation of muscle mass and fewer gastrointestinal side effects. However, current evidence is limited to animal studies. Patients should consult healthcare providers regarding the safety, dosage, and regulatory status of these peptides, as they are not yet standard FDA-approved treatments for obesity.

LimitedSupportsLOW confidence
In obese mice, 2 weeks of BRP treatment led to a mean weight loss of 4 g, predominantly from body fat rather than muscle... In contrast, semaglutide resulted in an approximate 9 g of weight loss. This reduction was not only in fats, but also from muscle and bone loss... Natural peptides, on the other hand, provide a promising action with minimal side effects.
Muhammad Affan Abid et al. · Medicine Advances · 2025

Why this rating

The paper cites animal studies (mice, pigs, rats) and preclinical data; no human efficacy trials are reported for the natural peptides.

Source

Natural Peptides Versus Semaglutide: A Safer Approach to Obesity Management

Muhammad Affan Abid et al. · Medicine Advances · 2025

DOI 10.1002/med4.70021

narrative_reviewCited 1×
Read the paper
DOI resolved against Crossref · corpus check 2026-06-10

This is one finding among thousands. Every one is graded and traced to its source, so you can see what the evidence actually supports. Browse the research →